SF
DERM icon

Summit Financial’s Journey Medical DERM Stock Holding History

Summit Financial’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.78M Sell
379,807
-10,612
-3% -$82.4K 0.02% 608
2025
Q4 		$3.01M Buy
390,419
+10,590
+3% +$83K 0.04% 379
2025
Q3 		$2.7M Buy
+379,829
New +$2.76M 0.04% 403

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Summit Financial's DERM Position: Q1 2026 in Review

Summit Financial reduced its Journey Medical (DERM) stake by 2.7% in Q1 2026, selling an estimated $82.4K and leaving 379,807 shares worth $1.78M. The position accounts for 0.02% of the portfolio, ranked #608.

Summit Financial first reported a position in DERM in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.01M in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Summit Financial held 379,807 shares of Journey Medical worth $1.78M as of Q1 2026.
  • Summit Financial sold 10,612 Journey Medical shares in Q1 2026, an estimated $82.4K.
  • Journey Medical made up 0.02% of Summit Financial's portfolio in Q1 2026, its #608 holding.
  • Summit Financial first reported a position in Journey Medical in Q3 2025 and has held it in 3 quarters since.
  • Summit Financial's Journey Medical position peaked at $3.01M in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Summit Financial's 13F filing for Q1 2026, filed 15 May 2026.